Daily as of 3 Nov 16:00 ET
- Price
- between the two $34.40 vs 50 $39.96 / 200 $31.46
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 6 May 2026 · projected 29 bars out
URGN | UroGen PharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$34.40
+$0.04 (+0.12%)
UroGen Pharma (URGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $32.72 vs 50 $29.76 / 200 $17.56
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 4 Aug 2025 · projected 7 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $34.40 vs 50 $36.69 / 200 $40.28
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 21 Oct 2026 · projected 22 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Oct 2026 | 💀Death | 4-hour | 22 bars out | Not tested |
| 6 May 2026 | 🟨Golden moderate | daily | 29 bars out | Not tested |
| 29 Apr 2026 | 🟨Golden | 4-hour | 26 bars out | Not tested |
| 8 Apr 2026 | 💀Death flat | daily | 16 bars out | 3 bar cross test |
| 4 Feb 2026 | 💀Death | 4-hour | 23 bars out | 5 bar cross test |
About URGN
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$31.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid